Kallikrein inhibitors and uses thereof

Details for Australian Patent Application No. 2005289621 (hide)

Owner Dyax Corp.

Inventors Ley, Arthur C.; De Simoni, Maria Grazia; Beck, Thomas; Hirani, Shirish; Bergamaschini, Luigi; Blair, Henry; Williams, Anthony; Ladner, Robert C.

Agent Cullens

Pub. Number AU-B-2005289621

PCT Pub. Number WO2006/036860

Priority 11/125,639 09.05.05 US; 10/953,902 27.09.04 US

Filing date 22 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 2 June 2011

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/036860 Priority application(s): WO2006/036860

2 June 2011 Application Accepted

  Published as AU-B-2005289621

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005289622-Anti-cavitation valve assembly

2005289610-Self-constrained segmented stents and methods for their deployment